Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Polyclonal activators in pulmonary immune disease.

Literature DB >> 2985229

Polyclonal activators in pulmonary immune disease.

W F Willoughby, J B Willoughby, G F Gerberick.

Abstract

Entities: Disease

Mesh：

Substances：
Mitogens
Cyclic AMP

Year: 1985 PMID： 2985229 DOI： 10.1007/bf02992983

Source DB: PubMed Journal: Clin Rev Allergy ISSN： 0731-8235

× No keyword cloud information.

99 in total

1. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors: H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal: Immunology Date: 1977-06 Impact factor: 7.397

2. Activation of B lymphocytes by locally concentrated concanavalin A.

Authors: J Andersson; G M Edelman; G Möller; O Sjöberg
Journal: Eur J Immunol Date: 1972-06 Impact factor: 5.532

3. Quantitation of the number of mitogen molecules activating DNA synthesis in T and B lymphocytes.

Authors: G Möller; J Andersson; H Pohlit; O Sjöberg
Journal: Clin Exp Immunol Date: 1973-01 Impact factor: 4.330

4. Relationships between the structure and activities of concanavalin A.

Authors: G N Reeke; J W Becker; B A Cunningham; G R Gunther; J L Wang; G M Edelman
Journal: Ann N Y Acad Sci Date: 1974 Impact factor: 5.691

5. Inflammation induced by concanavalin A and other lectins.

Authors: W T Shier; J T Trotter; C L Reading
Journal: Proc Soc Exp Biol Med Date: 1974-06

6. Unraveling pulmonary fibrosis: the bleomycin model.

Authors: D H Bowden
Journal: Lab Invest Date: 1984-05 Impact factor: 5.662

7. Polyclonal B-cell activation induced by extracts of Gram-negative bacteria isolated from periodontally diseased sites.

Authors: P H Bick; A B Carpenter; L V Holdeman; G A Miller; R R Ranney; K G Palcanis; J G Tew
Journal: Infect Immun Date: 1981-10 Impact factor: 3.441

Polyclonal activators in pulmonary immune disease.

1. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

2. Activation of B lymphocytes by locally concentrated concanavalin A.

3. Quantitation of the number of mitogen molecules activating DNA synthesis in T and B lymphocytes.

4. Relationships between the structure and activities of concanavalin A.

5. Inflammation induced by concanavalin A and other lectins.

6. Unraveling pulmonary fibrosis: the bleomycin model.

7. Polyclonal B-cell activation induced by extracts of Gram-negative bacteria isolated from periodontally diseased sites.

Review 8. Overview of occupational immunologic lung disease.

Review 9. Phospholipid methylation and biological signal transmission.

10. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

1. Suppressor cell activity of human alveolar macrophages in interstitial lung diseases.